Omaxe [OMAXE] vs National Standard [NATIONSTD] Detailed Stock Comparison
Omaxe
NSE
Loading...
National Standard
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Omaxe wins in 8 metrics, National Standard wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Omaxe | National Standard | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2.48 | 345.14 | Omaxe |
| Price-to-Book Ratio | N/A | 14.45 | N/A |
| Debt-to-Equity Ratio | -4.06 | 0.00 | Omaxe |
| PEG Ratio | 13.33 | -33.03 | National Standard |
| EV/EBITDA | -2.94 | -3,376.39 | National Standard |
| Profit Margin (TTM) | -43.95% | 51.76% | National Standard |
| Operating Margin (TTM) | -21.73% | -5.32% | National Standard |
| Return on Equity | -468.38% | 4.85% | National Standard |
| Return on Assets (TTM) | -2.81% | 4.76% | National Standard |
| Free Cash Flow (TTM) | $9.83B | $-82.60M | Omaxe |
| 1-Year Return | -21.71% | -57.42% | Omaxe |
| Price-to-Sales Ratio (TTM) | 1.09 | 176.41 | Omaxe |
| Enterprise Value | $17.86B | $39.34B | National Standard |
| EV/Revenue Ratio | 1.14 | 176.40 | Omaxe |
| Gross Profit Margin (TTM) | -11.23% | N/A | N/A |
| Revenue per Share (TTM) | $85 | $11 | Omaxe |
| Earnings per Share (Diluted) | $-37.51 | $5.70 | National Standard |
| Beta (Stock Volatility) | -0.37 | 0.03 | Omaxe |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Omaxe vs National Standard Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Omaxe | -2.86% | -2.88% | -7.37% | 32.53% | 0.35% | -14.75% |
| National Standard | -3.80% | -11.64% | -27.25% | -44.11% | -53.21% | -57.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Omaxe | -21.71% | -8.00% | 25.12% | -31.18% | -10.86% | -66.15% |
| National Standard | -57.42% | -64.06% | 811.42% | 10,927.92% | 10,927.92% | 10,927.92% |
Performance & Financial Health Analysis: Omaxe vs National Standard
| Metric | OMAXE | NATIONSTD |
|---|---|---|
| Market Information | ||
| Market Cap | ₹17.07B | ₹39.35B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 350,202 | 255 |
| 90 Day Avg. Volume | 661,369 | 242 |
| Last Close | ₹92.01 | ₹1,817.25 |
| 52 Week Range | ₹68.91 - ₹135.90 | ₹1,801.05 - ₹6,195.00 |
| % from 52W High | -32.30% | -70.67% |
| All-Time High | ₹486.31 (Dec 10, 2007) | ₹19,000.00 (Nov 15, 2021) |
| % from All-Time High | -81.08% | -90.44% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | -1.00% |
| Quarterly Earnings Growth | 0.06% | -0.63% |
| Financial Health | ||
| Profit Margin (TTM) | -0.44% | 0.52% |
| Operating Margin (TTM) | -0.22% | -0.05% |
| Return on Equity (TTM) | -4.68% | 0.05% |
| Debt to Equity (MRQ) | -4.06 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹-11.22 | ₹136.17 |
| Cash per Share (MRQ) | ₹40.68 | ₹0.13 |
| Operating Cash Flow (TTM) | ₹10.07B | ₹-3,741,000 |
| Levered Free Cash Flow (TTM) | ₹10.08B | ₹131.99M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Omaxe vs National Standard
| Metric | OMAXE | NATIONSTD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2.48 | 345.14 |
| Forward P/E | 13.33 | N/A |
| PEG Ratio | 13.33 | -33.03 |
| Price to Sales (TTM) | 1.09 | 176.41 |
| Price to Book (MRQ) | N/A | 14.45 |
| Market Capitalization | ||
| Market Capitalization | ₹17.07B | ₹39.35B |
| Enterprise Value | ₹17.86B | ₹39.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.14 | 176.40 |
| Enterprise to EBITDA | -2.94 | -3,376.39 |
| Risk & Other Metrics | ||
| Beta | -0.37 | 0.03 |
| Book Value per Share (MRQ) | ₹-11.22 | ₹136.17 |
Financial Statements Comparison: Omaxe vs National Standard
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OMAXE | NATIONSTD |
|---|---|---|
| Revenue/Sales | ₹5.41B | ₹0 |
| Cost of Goods Sold | ₹6.02B | ₹0 |
| Gross Profit | ₹-608.00M | ₹0 |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-1.18B | ₹-28.50M |
| EBITDA | ₹-943.20M | ₹-28.50M |
| Pre-Tax Income | ₹-1.57B | ₹14.87M |
| Income Tax | ₹-85.80M | ₹5.00M |
| Net Income (Profit) | ₹-1.49B | ₹9.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OMAXE | NATIONSTD |
|---|---|---|
| Cash & Equivalents | ₹3.01B | ₹2.58M |
| Total Current Assets | ₹132.60B | ₹2.70B |
| Total Current Liabilities | ₹139.53B | ₹48.18M |
| Long-Term Debt | ₹5.34B | N/A |
| Total Shareholders Equity | ₹-1.96B | ₹2.72B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹5.26B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OMAXE | NATIONSTD |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | OMAXE | NATIONSTD |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 350,202 | 255 |
| Average Daily Volume (90 Day) | 661,369 | 242 |
| Shares Outstanding | 182.90M | 20.00M |
| Float Shares | 38.24M | 310,000 |
| % Held by Insiders | 0.79% | 0.98% |
| % Held by Institutions | 0.05% | 0.00% |
Dividend Analysis & Yield Comparison: Omaxe vs National Standard
| Metric | OMAXE | NATIONSTD |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |